CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sotac Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sotac Pharmaceuticals Ltd
AHMEDABAD, 382110  India Ticker: SOTACSOTAC
Business Summary
Sotac Pharmaceuticals Limited is an India-based company. The Company is a is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-lactam Syrup and external preparations. The Company is engaged in the business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company’s therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, Cephalosporin. Its pharmaceutical manufacturing facilities are situated at Sanand GIDC-II in Ahmedabad district of Gujarat.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20233/31/2023-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Managing Director, Executive Chairman Sharadkumar D.Patel 43 12/12/2022 12/12/2022
Chief Financial Officer Brijeshkumar R.Patel 12/30/2022 12/30/2022
Chief Compliance Officer, Company Secretary Niyati D.Parikh 8/11/2023 8/11/2023
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 89 (As of 9/30/2022)
Outstanding Shares: 11,050,000 (As of 10/20/2023)
Stock Exchange: NSE
Email Address: sotacpharma@gmail.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024